Earnings Call · Q2 FY2024·2024-08-01

Q2 24EPS -9.19%·Rev n/aQ1 24EPS +17.24%·Rev n/aQ4 23EPS +2.69%·Rev n/aQ3 23EPS +2.77%·Rev n/a⚠ consensus missing

VERTEX PHARMACEUTICALS INC / MA VRTX

Susie Lisa — Senior Vice President, Investor Relations

Reshma Kewalramani — Chief Executive Officer and President

Stuart Arbuckle — Chief Operating Officer

Charlie Wagner — Chief Financial Officer

−2.2%1d on move date−0.4% vs SPY3d−6.2%5d−7.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VRTX calls or request research access.

More VRTX calls Browse calls Request research access